| High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells | |
| Zhaoduan Liang; Yanyan Li; Ye Tian; Huanling Zhang; Wenxuan Cai; Anan Chen; Lin Chen; Yifeng Bao; Bo Xiang; Heping Kan | |
| 刊名 | Cancer Letters
 |
| 2019 | |
| 关键词 | protein engineering hPD-L1 T cells cancer immunotherapy |
| ISSN号 | 0304-3835 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4605299 |
| 专题 | 湖南大学 |
| 作者单位 | 1.b School of Life Sciences, University of Science and Technology of China, No. 96, Jinzhai Road, Hefei, Anhui province, China a State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 190 Kai Yuan Avenue, Science Park, Guangzhou, Guangdong province, China 2.Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, 1838, North Guangzhou Avenue, Baiyun District, Guangzhou, Guangdong province, China |
| 推荐引用方式 GB/T 7714 | Zhaoduan Liang,Yanyan Li,Ye Tian,et al. High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells[J]. Cancer Letters,2019. |
| APA | Zhaoduan Liang.,Yanyan Li.,Ye Tian.,Huanling Zhang.,Wenxuan Cai.,...&Yi Li.(2019).High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells.Cancer Letters. |
| MLA | Zhaoduan Liang,et al."High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells".Cancer Letters (2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论